Haloperidol and lithium carbonate treatment did not influence serum immunoglobulin levels in schizophrenic and affective patients
| Autor: | B. Spivak, M Radwan, P. Bartur, Samuel Tyano, Jonathan Brandon, Abraham Weizman |
|---|---|
| Rok vydání: | 1991 |
| Předmět: |
Adult
Male medicine.medical_specialty Psychosis Bipolar Disorder Lithium (medication) Adolescent Immunoglobulins Immunoglobulin E Gastroenterology Serology chemistry.chemical_compound Lithium Carbonate Internal medicine mental disorders Schizophrenic Psychology medicine Haloperidol Humans Psychiatry Depressive Disorder biology Lithium carbonate Middle Aged medicine.disease Psychiatry and Mental health chemistry Schizophrenia Chronic Disease biology.protein Female Psychology medicine.drug |
| Zdroj: | Acta psychiatrica Scandinavica. 84(3) |
| ISSN: | 0001-690X |
| Popis: | Serum immunoglobulin levels were studied in 153 psychiatric patients (87 schizophrenic, 48 bipolar and 18 unipolar patients), and 35 healthy controls. Psychotropic treatments (haloperidol in the schizophrenic patients and lithium in the bipolar affective patients) did not alter serum immunoglobulin levels. Decreased mean IgM serum level was detected in the major affective patients (unipolar and bipolar) compared with normal controls. Nonspecific environmental, infectious, autoimmune and emotional factors that can play a role in the alterations obtained in psychiatric patients are discussed. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text